MSU
AHCO icon

Mizuho Securities USA’s AdaptHealth AHCO Stock Holding History

Mizuho Securities USA’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-65,000
Closed -$662K – 165
2019
Q3 		$662K Buy
+65,000
New +$663K 0.04% 114

Other funds holding AHCO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AIM
Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
MAM
Myriad Asset Management North Point, Hong Kong $722M AUM 11.94% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mizuho Securities USA's AHCO Position: Q4 2019 in Review

Mizuho Securities USA sold out of AdaptHealth (AHCO) in Q4 2019, closing a stake of 65,000 shares — an estimated $662K sold.

Mizuho Securities USA first reported a position in AHCO in Q3 2019 and held it in 1 quarter. The position peaked at $662K in Q3 2019. 23 funds tracked by Wall St. Rank hold AHCO as of Q4 2019.

  • Mizuho Securities USA reported no remaining AdaptHealth position as of Q4 2019 after selling out during the quarter.
  • Mizuho Securities USA sold 65,000 AdaptHealth shares in Q4 2019, an estimated $662K.
  • Mizuho Securities USA first reported a position in AdaptHealth in Q3 2019 and held it in 1 quarter.
  • Mizuho Securities USA's AdaptHealth position peaked at $662K in Q3 2019.
  • 23 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2019.

Based on Mizuho Securities USA's 13F filing for Q4 2019, filed 30 Jan 2020.